This subgroup shows an intermediate overall survival between the wild-type and mutant groups, with nearly significant and equivalent differences between the different categories (data not shown).
← all excerpts
Intra-tumor heterogeneity in TP53 null High Grade Serous Ovarian Carcinoma progression.
1
—
—